AR is a member of the nuclear receptor superfamily that functions as a ligand-dependent transcription factor, and AR gene overexpression has been described in 30–50% of castration-resistant prostate cancer (CRPC) patients, indicating that AR plays an important role in the development of PCa [35,36]. Here, AR is linked to posterior cortical atrophy.